ABT rides on strong global demand in diagnostics and diabetes care, but macro headwinds may test its momentum ahead.
Vous n'êtes pas connecté
ABT stock surges 21.7% year to date on CGM sales growth and robust diagnostics demand, even as FX and macro risks weigh on forecasts.
ABT rides on strong global demand in diagnostics and diabetes care, but macro headwinds may test its momentum ahead.
SFM surges ahead with robust sales growth, digital gains and store expansion as TGT faces slow traffic and softer guidance.
ITT sees segment-wide momentum and boosts from acquisitions, but rising costs and FX headwinds weigh on growth.
ITT sees segment-wide momentum and boosts from acquisitions, but rising costs and FX headwinds weigh on growth.
TSM rides AI chip demand to display strong growth despite volatility and rising geopolitical risks.
TSM rides AI chip demand to display strong growth despite volatility and rising geopolitical risks.
AYI surges on strong Q3 results as acquisitions and tech-driven segments power 23% EPS growth and margin gains.
AYI surges on strong Q3 results as acquisitions and tech-driven segments power 23% EPS growth and margin gains.
QBTS surges as D-Wave's Advantage2 system sees strong adoption across AI, defense and quantum optimization use cases.
QBTS surges as D-Wave's Advantage2 system sees strong adoption across AI, defense and quantum optimization use cases.